Examination of irreversible platelet-fibrinogen interactions.

The progressive stabilization of fibrinogen binding to ADP-treated platelets has been well described, but the nature of this interaction remains obscure. In the present study, irreversibly bound fibrinogen was defined as that fraction of bound iodinated fibrinogen that failed to dissociate from stimulated human gel-filtered platelets within 10 min of adding 10 mM ethylenediaminetetraacetic acid. It represented 16 +/- 11% (mean +/- SD, n = 10) of fibrinogen bound to ADP-treated platelets after 1 min and 52 +/- 11% of fibrinogen bound to these platelets after 60 min. Similar results were obtained if platelets were stimulated with purified human thrombin (0.1 U/ml) or epinephrine (10 microM). Irreversible fibrinogen binding was significantly reduced at 4 degrees C (27 +/- 9%, mean +/- SD, n = 6) if platelets were preincubated (30 min, 25 degrees C) with 30 micrograms/ml cytochalasin B or D (18 +/- 8%) or stimulated with chymotrypsin (0.5 mg/2-3 X 10(8) platelets) (31 +/- 8%). Formation of irreversible platelet-fibrinogen interactions correlated with the incorporation of actin and actin-binding protein into the Triton X-100-insoluble platelet cytoskeleton and the ability of platelets to retract fibrin clots. Irreversibly bound fibrinogen was available on platelets for digestion by 0.2 U/ml plasmin. The enzyme removed 96 +/- 6% (mean +/- SD, n = 6) of all bound fibrinogen from platelets after 30 min at 25 degrees C. This was not accompanied by significant release of [14C]serotonin or lactate dehydrogenase. Furthermore, platelets incubated with plasmin could bind fibrinogen normally after the enzyme had been neutralized with aprotinin.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  G. Tuszynski,et al.  Association of fibronectin with the platelet cytoskeleton. , 1984, The Journal of biological chemistry.

[2]  E. Peerschke Observations on the Effects of Cytochalasin B and Cytochalasin D on ADP- and Chymotrypsin-Treated Platelets , 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[3]  Nachmias Vt Platelet and megakaryocyte shape change: triggered alterations in the cytoskeleton. , 1983 .

[4]  B. Coller,et al.  A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. , 1983, The Journal of clinical investigation.

[5]  N. Masiello,et al.  The Triton X-100-insoluble residue ("cytoskeleton") of aggregated platelets contains increased lipid phosphorus as well as 125I-labeled glycoproteins , 1983 .

[6]  P. Cuatrecasas,et al.  Cytochalasins inhibit arachidonic acid metabolism in thrombin-stimulated platelets. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Zobel,et al.  Cytochalasin B binding by human platelets , 1982, Journal of cellular physiology.

[8]  E. Peerschke Evidence for interaction between platelet fibrinogen receptors , 1982 .

[9]  L. Jennings,et al.  Purification of glycoproteins IIb and III from human platelet plasma membranes and characterization of a calcium-dependent glycoprotein IIb-III complex. , 1982, The Journal of biological chemistry.

[10]  E. Peerschke Induction of human platelet fibrinogen receptors by epinephrine in the absence of released ADP , 1982 .

[11]  Carl Frieden,et al.  Cytochalasin D and platelet gelsolin accelerate actin polymer formation. A model for regulation of the extent of actin polymer formation in vivo. , 1982, Biochemistry.

[12]  A. Rotman,et al.  Dynamics of membrane-cytoskeleton interactions in activated blood platelets. , 1982, Biochemistry.

[13]  J. White,et al.  Ultrastructure of clots during isometric contraction , 1982, The Journal of cell biology.

[14]  A. Rotman,et al.  Association of membrane and cytoplasmic proteins with the cytoskeleton in blood platelets. , 1982, Biochemistry.

[15]  L. Leung,et al.  Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. , 1982, The Journal of clinical investigation.

[16]  M. Ginsberg,et al.  Concanavalin A induces interactions between surface glycoproteins and the platelet cytoskeleton , 1982, The Journal of cell biology.

[17]  J. Fox,et al.  Inhibition of actin polymerization in blood platelets by cytochalasins , 1981, Nature.

[18]  B. Coller Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents. , 1981, Blood.

[19]  E. Plow,et al.  Interaction of fibrinogen with its platelet receptor: kinetics and effect of pH and temperature. , 1981, Biochemistry.

[20]  L. Jennings,et al.  Identification of membrane proteins mediating the interaction of human platelets , 1980, The Journal of cell biology.

[21]  R. Grant,et al.  Correlation between fibrinogen binding to human platelets and platelet aggregability , 1980 .

[22]  E. Peerschke,et al.  Relationship of ADP-Induced Fibrinogen Binding to Platelet Shape Change and Aggregation Elucidated by Use of Colchicine and Cytochalasin B , 1980, Thrombosis and Haemostasis.

[23]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.